Prevention of renarcotization from synthetic opioids
Ended Project Grant Awarded Last action
- Award ID
- R41DA050386
- Recipient
-
Consegna Pharma Inc. UEI NU7SAKDR52N8
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $305,204
Award facts
- Assistance listing
- 93.279 Drug Use and Addiction Research Programs
- Completion date
- Originally
- Place of performance
- Pennsylvania, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $87,234 | |
| Amendment | $0 | |
| Original award | $217,970 |
Quick answers
Who received award R41DA050386?
R41DA050386 was awarded to Consegna Pharma Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 30, 2019.
How much is award R41DA050386 worth?
$305,204 has been obligated on R41DA050386.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award